Xact Kapitalforvaltning’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.78M Hold
11,695
0.04% 365
2019
Q4
$1.76M Hold
11,695
0.03% 448
2019
Q3
$1.66M Hold
11,695
0.03% 425
2019
Q2
$1.46M Hold
11,695
0.03% 444
2019
Q1
$1.29M Hold
11,695
0.03% 490
2018
Q4
$1.15M Buy
11,695
+600
+5% +$65.1K 0.03% 495
2018
Q3
$1.37M Hold
11,095
0.03% 502
2018
Q2
$1.1M Buy
11,095
+1,700
+18% +$156K 0.02% 557
2018
Q1
$829K Buy
9,395
+2,900
+45% +$271K 0.02% 605
2017
Q4
$641K Buy
+6,495
New +$637K 0.02% 609

Other funds holding WST

Xact Kapitalforvaltning's WST Position: Q1 2020 in Review

Xact Kapitalforvaltning held its West Pharmaceutical (WST) position steady in Q1 2020 at 11,695 shares worth $1.78M. The position accounts for 0.04% of the portfolio, ranked #365.

Xact Kapitalforvaltning first reported a position in WST in Q4 2017 and has held it in 10 quarters since. 469 funds tracked by Wall St. Rank hold WST as of Q1 2020.

  • Xact Kapitalforvaltning held 11,695 shares of West Pharmaceutical worth $1.78M as of Q1 2020.
  • Xact Kapitalforvaltning left its West Pharmaceutical share count unchanged in Q1 2020.
  • West Pharmaceutical made up 0.04% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #365 holding.
  • Xact Kapitalforvaltning first reported a position in West Pharmaceutical in Q4 2017 and has held it in 10 quarters since.
  • 469 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.